Phibro Animal Health Corporation (PAHC) to Distribute Quarterly Dividend of $0.12 on December 16th

Phibro Animal Health Corporation (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, November 3rd. Investors of record on Wednesday, November 25th will be paid a dividend of $0.12 per share on Wednesday, December 16th. This represents a $0.48 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, November 25th.

Phibro Animal Health has a dividend payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Phibro Animal Health to earn $3.81 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 12.6%.

Phibro Animal Health Trading Up 4.7%

NASDAQ:PAHC opened at $39.43 on Thursday. The company has a market capitalization of $1.60 billion, a P/E ratio of 16.16 and a beta of 0.42. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. The firm has a fifty day simple moving average of $37.16 and a 200-day simple moving average of $41.09. Phibro Animal Health has a 12 month low of $28.25 and a 12 month high of $60.08.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, November 4th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.01. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. The firm had revenue of $386.77 million during the quarter, compared to the consensus estimate of $382.42 million. On average, equities research analysts anticipate that Phibro Animal Health will post 3.49 earnings per share for the current year.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.